These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 28993502)

  • 1. Cardiovascular Effects of Renal Distal Tubule Deletion of the FGF Receptor 1 Gene.
    Han X; Ross J; Kolumam G; Pi M; Sonoda J; King G; Quarles LD
    J Am Soc Nephrol; 2018 Jan; 29(1):69-80. PubMed ID: 28993502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FGF23 induced left ventricular hypertrophy mediated by FGFR4 signaling in the myocardium is attenuated by soluble Klotho in mice.
    Han X; Cai C; Xiao Z; Quarles LD
    J Mol Cell Cardiol; 2020 Jan; 138():66-74. PubMed ID: 31758962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conditional Deletion of Fgfr1 in the Proximal and Distal Tubule Identifies Distinct Roles in Phosphate and Calcium Transport.
    Han X; Yang J; Li L; Huang J; King G; Quarles LD
    PLoS One; 2016; 11(2):e0147845. PubMed ID: 26839958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of renal phosphate transport by FGF23 is mediated by FGFR1 and FGFR4.
    Gattineni J; Alphonse P; Zhang Q; Mathews N; Bates CM; Baum M
    Am J Physiol Renal Physiol; 2014 Feb; 306(3):F351-8. PubMed ID: 24259513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FGF23 regulates renal sodium handling and blood pressure.
    Andrukhova O; Slavic S; Smorodchenko A; Zeitz U; Shalhoub V; Lanske B; Pohl EE; Erben RG
    EMBO Mol Med; 2014 Jun; 6(6):744-59. PubMed ID: 24797667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular Interactions between Fibroblast Growth Factor-23 and Angiotensin II.
    Pi M; Ye R; Han X; Armstrong B; Liu X; Chen Y; Sun Y; Quarles LD
    Sci Rep; 2018 Aug; 8(1):12398. PubMed ID: 30120363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential regulation of renal Klotho and FGFR1 in normal and uremic rats.
    Muñoz-Castañeda JR; Herencia C; Pendón-Ruiz de Mier MV; Rodriguez-Ortiz ME; Diaz-Tocados JM; Vergara N; Martínez-Moreno JM; Salmerón MD; Richards WG; Felsenfeld A; Kuro-O M; Almadén Y; Rodríguez M
    FASEB J; 2017 Sep; 31(9):3858-3867. PubMed ID: 28515153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FGF23 decreases renal NaPi-2a and NaPi-2c expression and induces hypophosphatemia in vivo predominantly via FGF receptor 1.
    Gattineni J; Bates C; Twombley K; Dwarakanath V; Robinson ML; Goetz R; Mohammadi M; Baum M
    Am J Physiol Renal Physiol; 2009 Aug; 297(2):F282-91. PubMed ID: 19515808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compound deletion of Fgfr3 and Fgfr4 partially rescues the Hyp mouse phenotype.
    Li H; Martin A; David V; Quarles LD
    Am J Physiol Endocrinol Metab; 2011 Mar; 300(3):E508-17. PubMed ID: 21139072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple faces of fibroblast growth factor-23.
    Han X; Quarles LD
    Curr Opin Nephrol Hypertens; 2016 Jul; 25(4):333-42. PubMed ID: 27219044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble α-klotho and heparin modulate the pathologic cardiac actions of fibroblast growth factor 23 in chronic kidney disease.
    Yanucil C; Kentrup D; Campos I; Czaya B; Heitman K; Westbrook D; Osis G; Grabner A; Wende AR; Vallejo J; Wacker MJ; Navarro-Garcia JA; Ruiz-Hurtado G; Zhang F; Song Y; Linhardt RJ; White K; Kapiloff MS; Faul C
    Kidney Int; 2022 Aug; 102(2):261-279. PubMed ID: 35513125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble Klotho Protects against Uremic Cardiomyopathy Independently of Fibroblast Growth Factor 23 and Phosphate.
    Xie J; Yoon J; An SW; Kuro-o M; Huang CL
    J Am Soc Nephrol; 2015 May; 26(5):1150-60. PubMed ID: 25475745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha Klotho and Fibroblast Growth Factor-23 Among Alcoholics.
    Quintero-Platt G; González-Reimers E; Rodríguez-Gaspar M; Martín-González C; Pérez-Hernández O; Romero-Acevedo L; Espelosín-Ortega E; Vega-Prieto MJ; Santolaria-Fernández F
    Alcohol Alcohol; 2017 Sep; 52(5):542-549. PubMed ID: 28651327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteocyte-specific deletion of Fgfr1 suppresses FGF23.
    Xiao Z; Huang J; Cao L; Liang Y; Han X; Quarles LD
    PLoS One; 2014; 9(8):e104154. PubMed ID: 25089825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pleiotropic Actions of FGF23.
    Erben RG
    Toxicol Pathol; 2017 Oct; 45(7):904-910. PubMed ID: 29096595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted deletion of Klotho in kidney distal tubule disrupts mineral metabolism.
    Olauson H; Lindberg K; Amin R; Jia T; Wernerson A; Andersson G; Larsson TE
    J Am Soc Nephrol; 2012 Oct; 23(10):1641-51. PubMed ID: 22878961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble α-klotho anchors TRPV5 to the distal tubular cell membrane independent of FGFR1 by binding TRPV5 and galectin-1 simultaneously.
    Lee J; Ju KD; Kim HJ; Tsogbadrakh B; Ryu H; Kang E; Kang M; Yang J; Kang HG; Ahn C; Oh KH
    Am J Physiol Renal Physiol; 2021 Apr; 320(4):F559-F568. PubMed ID: 33615893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered renal FGF23-mediated activity involving MAPK and Wnt: effects of the Hyp mutation.
    Farrow EG; Summers LJ; Schiavi SC; McCormick JA; Ellison DH; White KE
    J Endocrinol; 2010 Oct; 207(1):67-75. PubMed ID: 20675303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FGFR3 and FGFR4 do not mediate renal effects of FGF23.
    Liu S; Vierthaler L; Tang W; Zhou J; Quarles LD
    J Am Soc Nephrol; 2008 Dec; 19(12):2342-50. PubMed ID: 18753255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Klotho Lacks an FGF23-Independent Role in Mineral Homeostasis.
    Andrukhova O; Bayer J; Schüler C; Zeitz U; Murali SK; Ada S; Alvarez-Pez JM; Smorodchenko A; Erben RG
    J Bone Miner Res; 2017 Oct; 32(10):2049-2061. PubMed ID: 28600880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.